HIGHLIGHTS
- who: Abdelrahim Alqudah and colleagues from the Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, have published the research: The Emerging Importance of Cirsimaritin in Type 2 Diabetes Treatment, in the Journal: (JOURNAL) of 15/03/2023
- what: The findings of this study demonstrated that cirsimaritin-improved insulin resistance is mediated by the activation of the AMPK-GLUT4 pathway in the skeletal and adipose_tissues, and by the activation of the AMPK-GLUT2 in the liver. This study showed that cirsimaritin improved the lipid profile in high-fat diabetic rats . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.